Crown Laboratories, Inc. ("Crown") and Revance Therapeutics, Inc. ("Revance"), today announced that the tender offer to purchase all of the issued and outstanding shares of common stock, par value $0 ...
Aspen Technology, Inc. ("AspenTech" or the "Company") (NASDAQ: AZPN), a global leader in industrial software, today announced financial results for its second quarter ...